Genomic analysis provides insights into the transmission and pathogenicity of Talaromyces marneffei.


Journal

Fungal genetics and biology : FG & B
ISSN: 1096-0937
Titre abrégé: Fungal Genet Biol
Pays: United States
ID NLM: 9607601

Informations de publication

Date de publication:
09 2019
Historique:
received: 27 04 2018
revised: 05 05 2019
accepted: 06 05 2019
pubmed: 11 5 2019
medline: 27 5 2020
entrez: 11 5 2019
Statut: ppublish

Résumé

Talaromyces marneffei (T. marneffei) is a medically important opportunistic dimorphic fungus that infects both humans and bamboo rats. However, the mechanisms of transmission and pathogenicity of T. marneffei are poorly understood. In our study, we combined Illumina and PacBio sequencing technologies to sequence and assemble a complete genome of T. marneffei. To elucidate the transmission route and source, we sequenced three additional T. marneffei isolates using Illumina sequencing technology. Variations among isolates were used to develop a multilocus sequence typing (MLST) system comprising five housekeeping genes that can be used to discriminate between isolates derived from different sources. Our analysis revealed that human and bamboo rat share identical genotypes in these five loci. Thus, we hypothesized that T. marneffei is transmitted to humans through inhalation of spores in the surrounding environment into the lungs and that the bamboo rat can serve as an important natural reservoir for pathogens. Furthermore, we also identified temperature-dependent polyketide synthases, non-ribosomal peptide synthetases and secreted proteins as putative pathogenicity-related factors. In addition, we identified antifungal drug targets that can be investigated in future studies to elucidate the mechanisms underlying drug resistance. In summary, our study presents the basic features of the T. marneffei genome and provides insights into the transmission and pathogenicity of T. marneffei, which warrant fundamental experimental research.

Identifiants

pubmed: 31075360
pii: S1087-1845(19)30149-5
doi: 10.1016/j.fgb.2019.05.002
pii:
doi:

Substances chimiques

Antifungal Agents 0
DNA, Fungal 0
Fungal Proteins 0
Virulence Factors 0
Polyketide Synthases 79956-01-7
Peptide Synthases EC 6.3.2.-
non-ribosomal peptide synthase EC 6.3.2.-

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

54-61

Informations de copyright

Copyright © 2019 Elsevier Inc. All rights reserved.

Auteurs

Yinghua Li (Y)

Department of Respiratory Medicine, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Honglin Luo (H)

School of Basic Medicine, Guangxi Medical University, Nanning, Guangxi, China.

Jiangtao Fan (J)

Department of Gynecology, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Xiuwan Lan (X)

Guangxi Colleges and Universities Key Laboratory of Preclinical Medicine Research, Nanning, Guangxi, China.

Guangnan Liu (G)

Department of Respiratory Medicine, the Second Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Jianquan Zhang (J)

Department of Respiratory Medicine, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Xiaoning Zhong (X)

Department of Respiratory Medicine, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Yan Pang (Y)

Department of Respiratory Medicine, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China.

Junning Wang (J)

Zeta Biosciences, Zhangjiang Hi-Tech Park, Shanghai, China.

Zhiyi He (Z)

Department of Respiratory Medicine, the First Affiliated Hospital of Guangxi Medical University, Nanning, Guangxi, China. Electronic address: zhiyi-he@163.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH